New Delhi, 3 September (Kiran News): Shares of Anlon Healthcare, a manufacturer of pharmaceutical intermediates and active pharmaceutical ingredients, made a flat debut in the stock market today, disappointing many IPO investors. The company’s shares were listed at Rs. 91 per share on the BSE, the same as the IPO issue price, while on the NSE, the stock debuted with a modest 1% premium at Rs. 92.
Post-listing, Anlon Healthcare shares continued to trade in a narrow range. By 11:30 am, the stock was trading at Rs. 91.80 per share.
Anlon Healthcare’s Rs. 121 crore IPO was open for subscription from August 26 to August 29 and received a strong response from investors, being oversubscribed 7 times. The price band for the IPO was fixed at Rs. 86–91 per share. The company plans to use the funds raised to expand its manufacturing facility, repay old loans, meet working capital requirements, and for general corporate purposes.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
